more_reports

The Latest Regenerative Medicine Articles from Streetwise Reports

Genetic Medicines Co. Reveals Transformative 'Only-of-Its-Kind' AAV Therapy Milestone

  ()
MeiraGTx Holdings Plc (MGTX:NASDAQ) reports 3-year gene therapy results, secures US$100M funding, and advances late-stage pipeline, signaling major commercial potential.
Tags: Biotechnology / PharmaceuticalsRegenerative Medicine

Showing Results: 1 to 1 of 1